PBLS (PBLS) Stock Price & Analysis
PBLS (PBLS) fell 0.81% to USD 40.42 as of September 8, 2026 at 09:33 UTC, according to Nexqual real-time market data.
PBLS last closed at USD 40.42; the session ranged USD 39.5–41.19 on volume of 380,843 shares. Market capitalization is —, with a 52-week range of USD 24.51–41.49 (NMS). Source: Nexqual, September 8, 2026 at 09:33 UTC.
Key Statistics (as of September 8, 2026 at 09:33 UTC)
| Price | USD 40.42 |
|---|---|
| Change | ▼ 0.81% (down) |
| Previous Close | USD 40.42 |
| Open | USD 40.42 |
| Day Range | USD 39.5 – 41.19 |
| 52-Week Range | USD 24.51 – 41.49 |
| Volume | 380,843 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PBLS)
Nexqual's technical model rates PBLS "BUY" based on 5 bullish and 1 bearish signals across 61 daily candles, as of September 8, 2026 at 09:33 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 67.81 (neutral) |
| vs SMA50 | Above (USD 34.14) |
| MACD | 1.77 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KLRA | Kailera Therapeutics, Inc. | USD 16.23 | ▲ 2.4% |
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| EIKN | Eikon Therapeutics, Inc. | USD 10.86 | ▼ 4.57% |
| AVLN | Avalyn Pharma Inc. | USD 37.39 | ▲ 5.09% |
| MANE | Veradermics, Incorporated | USD 98.51 | ▲ 0.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:33 UTC. This page is informational and not investment advice.